Stephen Fowler Flatt - 23 Feb 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen Flatt
Issuer symbol
NHC
Transactions as of
23 Feb 2026
Net transactions value
$0
Form type
4
Filing time
25 Feb 2026, 17:18:43 UTC
Previous filing
05 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Flatt Stephen Fowler CEO, Director 100 VINE STREET, MURFREESBORO /s/ Stephen Flatt 25 Feb 2026 0001330766

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock 59,147 23 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +20,000 $0.000000 20,000 23 Feb 2026 Common Stock 20,000 $157.13 Direct F1, F2
holding NHC Option to Purchase Common Stock 6,147 23 Feb 2026 Common Stock 6,147 $53.94 Direct
holding NHC Option to Purchase Common Stock 10,000 23 Feb 2026 Common Stock 10,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 18,000 23 Feb 2026 Common Stock 18,000 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.